Medical News

RSS

NIH approves $6.6 million in funding for Phase 2a adult eradication study of Argos' AGS-004

Argos Therapeutics, Inc., a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases based on the Arcelis technology platform, today announced that the NIH Division of AIDS (DAIDS) has approved $6.6 million in funding for an investigator-initiated Phase 2a adult eradication study of AGS-004, the company’s investigational fully personalized immunotherapy for HIV.

2 Apr 2015

Bowel Cancer UK announces ambitious new move into bowel cancer research

Bowel Cancer UK is announcing an ambitious new agenda to become the UK’s leading research and campaigning charity dedicated to stopping bowel cancer for good, ahead of Bowel Cancer Awareness Month in April.

2 Apr 2015

Long-term effects of using cognitive-enhancing drugs by healthy people need to be determined

The government, pharmaceutical industry, and national medical organisations need to work together to look at the harms and benefits of long-term use of cognitive-enhancing drugs by healthy individuals, say neuroscientists Professor Barbara Sahakian and Dr Sharon Morein-Zamir from the University of Cambridge in the UK, writing in a Personal View in The Lancet Psychiatry journal.

2 Apr 2015

More access to postnatal care services can reduce death toll of infants, mothers

Depression associated with elevated risk for physical diseases

Those suffering from depressive symptoms have an increased risk for physical diseases, especially for arthrosis and arthritis. These findings were reported by researchers from the University of Basel and the Ruhr-University Bochum. Their results, based on data from 14,300 people living in Switzerland, have been published in the scientific journal "Frontiers in Public Health".

1 Apr 2015

Low doses of imatinib drug can push immune system to combat bacterial infections

Low doses of the anti-cancer drug imatinib can spur the bone marrow to produce more innate immune cells to fight against bacterial infections, Emory researchers have found.

1 Apr 2015

World-first human clinical trials for Hendra virus to begin this month

An antibody manufactured at The University of Queensland will be used in world-first human Hendra virus clinical trials starting this month.

1 Apr 2015

Scientists isolate energy-burning 'beige' fat from adult humans

For the first time, a research team, led by a UC San Francisco biologist, has isolated energy-burning "beige" fat from adult humans, which is known to be able to convert unhealthy white fat into healthy brown fat. The scientists also found new genetic markers of this beige fat.

1 Apr 2015

Some older people are diagnosed with cancer after emergency admission to hospital

People over 60 are at higher risk of being diagnosed with lung or bowel cancer as an emergency in hospital than younger people, according to a Cancer Research UK-supported report, published today by BMJ Open.

1 Apr 2015

McGraw-Hill Education introduces ObGyn Collection on AccessMedicine

McGraw-Hill Education, a leading global provider of content and services for the science, technical, and medical communities, announced the launch of the ObGyn Collection on AccessMedicine, the latest addition to the McGraw-Hill Education suite of comprehensive online resources for medical students, residents, and healthcare professionals.

1 Apr 2015

Screening people at risk of PTSD can help prevent further cases going unnoticed

When people have repeated non-specific health problems, it could be related to previous exposure to traumatic events. GPs may be seeing more patients with post-traumatic stress disorder (PTSD) as military personnel return from overseas deployments.

1 Apr 2015

Emmaus Life Sciences presents Phase 3 clinical trial of PGLG treatment for sickle cell disease

Emmaus Life Sciences, Inc., a biopharmaceutical company dedicated primarily to the discovery, development and commercialization of innovative treatments and therapies for rare and orphan diseases today announced that data from the Company’s Phase 3 clinical trial of its pharmaceutical grade L-glutamine (PGLG) treatment for sickle cell anemia and sickle beta-0 thalassemia, will be presented, during the 9th Annual Sickle Cell Disease Research and Educational Symposium and 38th National Sickle Cell Disease Scientific Meeting.

1 Apr 2015

New article highlights need for optimization of warfarin therapy

Warfarin can be a challenging drug to manage. Long-term anticoagulation is recommended for patients with atrial fibrillation at risk of stroke, and for those with recurrent venous thrombosis or prosthetic heart valves.

1 Apr 2015

Combined therapy boosts growth in short children with low IGF-1

Children with short stature benefit from receiving combined treatment with growth hormone and insulin-like growth factor-1, if they have low endogenous levels of the latter, a study shows.

1 Apr 2015

CVD risk assessment still important in severely obese adolescents

Researchers report a dose–response relationship between body mass index and cardiovascular risk even in severely obese adolescents, making its assessment important to limit further disease progression.

1 Apr 2015

Intensive therapy needed in paediatric triiodothyronine-predominant Graves' disease

Paediatric patients with triiodothyronine-predominant Graves' disease develop severe disease that needs increased doses of antithyroid drugs, a study shows.

1 Apr 2015

Idiopathic central precocious puberty on the rise in boys

About three-quarters of cases of central precocious puberty in boys have no identifiable cause, say researchers.

1 Apr 2015

Prolonged insulin therapy often unnecessary in children with Type 2 diabetes

Many children who require insulin treatment on diagnosis with Type 2 diabetes can be weaned off the medication, show findings from the run-in phase of the Treatment Options for Type 2 Diabetes in Adolescents and Youth study.

1 Apr 2015

NPS MedicineWise program focuses on optimal use of PPI therapy in GORD patients

NPS MedicineWise today launches a new learning program and health professional tools on the use of proton pump inhibitors (PPIs) in the treatment of uncomplicated gastro-oesophageal reflux disease (GORD).

1 Apr 2015

CABG surgery improves long-term survival in diabetic patients with severe heart disease

Among diabetic patients with severe heart disease, coronary artery bypass grafting (CABG) surgery is better than stenting (percutaneous coronary intervention; PCI) at improving long-term survival and reducing the risk of adverse complications, according to an article in the April 2015 issue of The Annals of Thoracic Surgery.

1 Apr 2015

Medical News

NIH approves $6.6 million in funding for Phase 2a adult eradication study of Argos' AGS-004

Bowel Cancer UK announces ambitious new move into bowel cancer research

Long-term effects of using cognitive-enhancing drugs by healthy people need to be determined

More access to postnatal care services can reduce death toll of infants, mothers

Depression associated with elevated risk for physical diseases

Low doses of imatinib drug can push immune system to combat bacterial infections

World-first human clinical trials for Hendra virus to begin this month

Scientists isolate energy-burning 'beige' fat from adult humans

Some older people are diagnosed with cancer after emergency admission to hospital

McGraw-Hill Education introduces ObGyn Collection on AccessMedicine

Screening people at risk of PTSD can help prevent further cases going unnoticed

Emmaus Life Sciences presents Phase 3 clinical trial of PGLG treatment for sickle cell disease

New article highlights need for optimization of warfarin therapy

Combined therapy boosts growth in short children with low IGF-1

CVD risk assessment still important in severely obese adolescents

Intensive therapy needed in paediatric triiodothyronine-predominant Graves' disease

Idiopathic central precocious puberty on the rise in boys

Prolonged insulin therapy often unnecessary in children with Type 2 diabetes

NPS MedicineWise program focuses on optimal use of PPI therapy in GORD patients

CABG surgery improves long-term survival in diabetic patients with severe heart disease

Lab Matters host Harriet Gould on building a more connected lab community

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

Latest News